SG11202110589PA - Biomarkers for selinexor - Google Patents
Biomarkers for selinexorInfo
- Publication number
- SG11202110589PA SG11202110589PA SG11202110589PA SG11202110589PA SG11202110589PA SG 11202110589P A SG11202110589P A SG 11202110589PA SG 11202110589P A SG11202110589P A SG 11202110589PA SG 11202110589P A SG11202110589P A SG 11202110589PA SG 11202110589P A SG11202110589P A SG 11202110589PA
- Authority
- SG
- Singapore
- Prior art keywords
- selinexor
- biomarkers
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Analytical Chemistry (AREA)
- Evolutionary Biology (AREA)
- Software Systems (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Computation (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962824877P | 2019-03-27 | 2019-03-27 | |
PCT/US2020/025275 WO2020198606A1 (en) | 2019-03-27 | 2020-03-27 | Biomarkers for selinexor |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202110589PA true SG11202110589PA (en) | 2021-10-28 |
Family
ID=70286034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202110589PA SG11202110589PA (en) | 2019-03-27 | 2020-03-27 | Biomarkers for selinexor |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220178927A1 (en) |
EP (1) | EP3946339A1 (en) |
KR (1) | KR20210143258A (en) |
CA (1) | CA3131720A1 (en) |
SG (1) | SG11202110589PA (en) |
WO (1) | WO2020198606A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112480082B (en) * | 2020-12-17 | 2022-05-17 | 天津市肿瘤医院 | Compound, preparation method and application thereof in preparation of medicine for treating small cell lung cancer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108348547B (en) | 2015-08-28 | 2023-09-22 | 纽约市哥伦比亚大学信托人 | System and method for matching oncology features |
CN106831731B (en) * | 2017-01-17 | 2019-11-08 | 广州市闻皓生物科技有限公司 | A kind of synthetic method of Selinexor bulk pharmaceutical chemicals |
-
2020
- 2020-03-27 CA CA3131720A patent/CA3131720A1/en active Pending
- 2020-03-27 WO PCT/US2020/025275 patent/WO2020198606A1/en unknown
- 2020-03-27 KR KR1020217034190A patent/KR20210143258A/en active Search and Examination
- 2020-03-27 SG SG11202110589PA patent/SG11202110589PA/en unknown
- 2020-03-27 EP EP20719103.2A patent/EP3946339A1/en active Pending
- 2020-03-27 US US17/598,101 patent/US20220178927A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20220178927A1 (en) | 2022-06-09 |
KR20210143258A (en) | 2021-11-26 |
CA3131720A1 (en) | 2020-10-01 |
WO2020198606A1 (en) | 2020-10-01 |
EP3946339A1 (en) | 2022-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201919219D0 (en) | Cancer biomarkers | |
GB2596456B (en) | Immunoassay for mitragynine | |
GB201902077D0 (en) | Biomarkers | |
GB201911947D0 (en) | Miscarriage biomarkers | |
GB201804648D0 (en) | Combination biomarker | |
GB201900677D0 (en) | Biomarkers | |
GB201811093D0 (en) | Biomarker | |
GB201814807D0 (en) | Dementia Biomarkers | |
SG11202110589PA (en) | Biomarkers for selinexor | |
GB202107813D0 (en) | Biomarker | |
GB201915228D0 (en) | Biomarkers | |
GB201902070D0 (en) | Biomarkers | |
GB201914183D0 (en) | Biomarker | |
GB201913846D0 (en) | Biomarker | |
GB201913612D0 (en) | Biomarker | |
GB201912154D0 (en) | Biomarker | |
GB201911078D0 (en) | Biomarker | |
GB201809854D0 (en) | Biomarkers | |
GB201809862D0 (en) | Biomarkers | |
GB201809878D0 (en) | Biomarkers | |
GB201809881D0 (en) | Biomarkers | |
GB201809885D0 (en) | Biomarkers | |
GB201809882D0 (en) | Biomarkers | |
GB201809868D0 (en) | Biomarkers | |
GB201809858D0 (en) | Biomarkers |